May 2020 Snapshot: The Impact of COVID-19 on Health Plans From a Pharmacy Point-of-View
The impact of COVID-19 on the health plan enterprise appears to be practical and functional rather than strategic and financial.
Boomerang Effect Of Gene Therapy on Oncology Contracting
The economics of one and done gene therapies dictate a revenue model that requires outcomes-based risk.
Oncology economics is the product of driving forces in the health insurance market that are intrinsic to oncology in managed care and unlikely to change.
2 Clarke Drive Cranbury, NJ 08512